ANGELA G LEE, MD
Medical Practice at Bascom Ave, San Jose, CA
License number
California A91541
Category
Medical Practice
Type
Pediatrics
Address
Address
751 S Bascom Ave DEPARTMENT PEDIATRICS, San Jose, CA 95128
Phone
(408) 885-5000
Personal information
See more information about ANGELA G LEE at radaris.comName
Address
Phone
4434 Campton Rd, Eureka, CA 95503
4388 El Camino Real UNIT 16, Los Altos, CA 94022
4408 E Dayton Ave, Fresno, CA 93726
465 E Geary St, Stockton, CA 95204
46 Summer Rim Cir, Sacramento, CA 95823
Professional information
Angela Lee - San Jose, CA
Work:
Abbott Vascular
Clinical Research Manager / Clinical Project Manager BRONCUS MEDICAL - Mountain View, CA
Clinical Affairs Consultant/Study Manager XLUMENA - Mountain View, CA
Study Manager IOGYN - Cupertino, CA
Clinical Affairs Consultant NEOTRACT - Pleasanton, CA
Continues Access Study Preparation Project Lead PORTAERO - Cupertino, CA
Clinical Research Associate BRONCUS TECHNOLOGIES - Mountain View, CA
Clinical Research Associate
Clinical Research Manager / Clinical Project Manager BRONCUS MEDICAL - Mountain View, CA
Clinical Affairs Consultant/Study Manager XLUMENA - Mountain View, CA
Study Manager IOGYN - Cupertino, CA
Clinical Affairs Consultant NEOTRACT - Pleasanton, CA
Continues Access Study Preparation Project Lead PORTAERO - Cupertino, CA
Clinical Research Associate BRONCUS TECHNOLOGIES - Mountain View, CA
Clinical Research Associate
Education:
China
BA in English Literature
BA in English Literature
Skills:
Computer Skills: Advanced MS Office user on both PC and Mac platform. Developing spreadsheets, word processing, manipulating databases, general computer knowledge. Language Skills: English: Fluent Chinese: Fluent Korean: Basic
Angela Gianforte Lee, Sunnyvale CA
Specialties:
Pediatrics
Work:
Valley Health Center at Sunnyvale Pediatrics
660 S Fair Oaks Ave, Sunnyvale, CA 94086 Pediatrics
751 S Bascom Ave, San Jose, CA 95128
660 S Fair Oaks Ave, Sunnyvale, CA 94086 Pediatrics
751 S Bascom Ave, San Jose, CA 95128
Education:
University of Arizona (2000)
Angela Gianforte Lee, San Jose CA
Specialties:
Pediatrician
Address:
751 S Bascom Ave, San Jose, CA 95128
660 S Fair Oaks Ave, Sunnyvale, CA 94086
660 S Fair Oaks Ave, Sunnyvale, CA 94086
Education:
Doctor of Medicine
Board certifications:
American Board of Pediatrics Certification in Pediatrics
Dr. Angela G Lee, Sunnyvale CA - MD (Doctor of Medicine)
Specialties:
Pediatrics, Anesthesiology
Age:
50
Address:
Valley Health Center Sunnyvale
660 S Fair Oaks Ave, Sunnyvale 94086
(408) 885-5000 (Phone)
660 S Fair Oaks Ave, Sunnyvale 94086
(408) 885-5000 (Phone)
Certifications:
Anesthesiology, 2006, Pediatrics, 2003
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Valley Health Center Sunnyvale
660 S Fair Oaks Ave, Sunnyvale 94086
Santa Clara Valley Medical Center
751 South Bascom Ave, San Jose 95128
Sutter Maternity and Surgery Center of Santa Cruz
2900 Chanticleer Ave, Santa Cruz 95065
660 S Fair Oaks Ave, Sunnyvale 94086
Santa Clara Valley Medical Center
751 South Bascom Ave, San Jose 95128
Sutter Maternity and Surgery Center of Santa Cruz
2900 Chanticleer Ave, Santa Cruz 95065
Education:
Medical School
University of Maryland At Baltimore / Professional Schools
Graduated: 2001
University of Maryland At Baltimore / Professional Schools
Graduated: 2001
Polyimidazoles For Use As Bile Acid Sequestrants
US Patent:
2013018, Jul 25, 2013
Filed:
Feb 24, 2011
Appl. No.:
13/581102
Inventors:
Inez Lees - Menlo Park CA, US
Kalpesh Biyani - Fremont CA, US
Eric Connor - Los Gatos CA, US
Scott Hecker - Del Mar CA, US
Hongmin Zhang - Fremont CA, US
Michael James Cope - Berkeley CA, US
Elizabeth Goka - San Jose CA, US
Angela Lee - San Jose CA, US
Deidre Madsen - Los Altos CA, US
Jun Shao - Fremont CA, US
Xinnan Zhang - Campbell CA, US
Kalpesh Biyani - Fremont CA, US
Eric Connor - Los Gatos CA, US
Scott Hecker - Del Mar CA, US
Hongmin Zhang - Fremont CA, US
Michael James Cope - Berkeley CA, US
Elizabeth Goka - San Jose CA, US
Angela Lee - San Jose CA, US
Deidre Madsen - Los Altos CA, US
Jun Shao - Fremont CA, US
Xinnan Zhang - Campbell CA, US
Assignee:
RELYPSA, INC. - Santa Clara CA
International Classification:
C08F 226/06, A61K 45/06, C08G 73/06, A61K 31/787
US Classification:
424 7801, 526258, 528392, 528393
Abstract:
The present invention provides crosslinked amine polymers effective for binding and removing bile salts from the gastrointestinal tract. These bile acid binding polymers or pharmaceutical compositions thereof can be administered to subjects to treat various conditions, including hypercholesteremia, diabetes, pruritus, irritable bowel syndrome-diarrhea (IBS-D), bile acid malabsorption, and the like.
Anion-Binding Polymers And Uses Thereof
US Patent:
7718746, May 18, 2010
Filed:
May 22, 2009
Appl. No.:
12/471220
Inventors:
Eric Connor - Los Gatos CA, US
Dominique Charmot - Campbell CA, US
Han-Ting Chang - Livermore CA, US
Florence Roger - Preverenges, CH
Gerrit Klaerner - San Jose CA, US
Son Hoai Nguyen - San Jose CA, US
Jonathan Mills - San Jose CA, US
Jerry M. Buysse - Los Altos CA, US
Angela Lee - San Jose CA, US
Deidre Madsen - Sunnyvale CA, US
Jun Shao - Fremont CA, US
Michael J. Cope - Berkeley CA, US
John Fordtran - Dallas TX, US
Dominique Charmot - Campbell CA, US
Han-Ting Chang - Livermore CA, US
Florence Roger - Preverenges, CH
Gerrit Klaerner - San Jose CA, US
Son Hoai Nguyen - San Jose CA, US
Jonathan Mills - San Jose CA, US
Jerry M. Buysse - Los Altos CA, US
Angela Lee - San Jose CA, US
Deidre Madsen - Sunnyvale CA, US
Jun Shao - Fremont CA, US
Michael J. Cope - Berkeley CA, US
John Fordtran - Dallas TX, US
Assignee:
Ilypsa, Inc. - Thousand Oaks CA
International Classification:
C08F 26/06, C07C 211/11
US Classification:
526310, 526258, 525334, 525374, 525526, 424 7806, 424 7811, 424 7812, 424 7816, 524612, 521 36, 564511, 564512
Abstract:
Anion-binding polymers are described. The anion-binding polymers in some cases are low swelling anion-binding polymers. In some cases, the anion-binding polymers have a pore volume distribution such that a fraction of the polymer is not available for non-interacting solutes above a certain percentage of the MW of the target ion for the polymer. In some cases, the anion-binding polymers are characterized by low ion-binding interference, where the interference is measured in, for example, a gastrointestinal simulant, relative to non-interfering buffer. Pharmaceutical composition, methods of use, and kits are also described.
Treatment Of Hyperphosphatemia Using Crosslinked Small Molecule Amine Polymers
US Patent:
7589238, Sep 15, 2009
Filed:
Aug 17, 2006
Appl. No.:
11/465444
Inventors:
Eric Connor - Los Gatos CA, US
Dominique Charmot - Campbell CA, US
Han Ting Chang - Livermore CA, US
Florence Roger - Santa Clara CA, US
Son Hoai Nguyen - San Jose CA, US
Jonathan Mills - San Jose CA, US
Jerry M. Buysse - Los Altos CA, US
Angela Lee - San Jose CA, US
Deidre Madsen - Sunnyvale CA, US
Jun Shao - Fremont CA, US
Michael J. Cope - Berkeley CA, US
John Fordtran - Dallas TX, US
Dominique Charmot - Campbell CA, US
Han Ting Chang - Livermore CA, US
Florence Roger - Santa Clara CA, US
Son Hoai Nguyen - San Jose CA, US
Jonathan Mills - San Jose CA, US
Jerry M. Buysse - Los Altos CA, US
Angela Lee - San Jose CA, US
Deidre Madsen - Sunnyvale CA, US
Jun Shao - Fremont CA, US
Michael J. Cope - Berkeley CA, US
John Fordtran - Dallas TX, US
Assignee:
Ilypsa, Inc. - Thousand Oaks CA
International Classification:
C07C 211/11, C08G 2/00
US Classification:
564511, 564512, 5147723, 525526, 521 36
Abstract:
Anion-binding polymers are described. The anion-binding polymers in some cases are low swelling anion-binding polymers. In some cases, the anion-binding polymers have a pore volume distribution such that a fraction of the polymer is not available for non-interacting solutes above a certain percentage of the MW of the target ion for the polymer. In some cases, the anion-binding polymers are characterized by low ion-binding interference, where the interference is measured in, for example, a gastrointestinal simulant, relative to non-interfering buffer. Pharmaceutical composition, methods of use, and kits are also described.
Crosslinked Polyvinylamine, Polyallylamine, And Polyethyleneimine For Use As Bile Acid Sequestrants
US Patent:
2013002, Jan 24, 2013
Filed:
Feb 24, 2011
Appl. No.:
13/581049
Inventors:
Jordan Kopping - Weinheim, DE
Kalpesh Biyani - Fremont CA, US
Eric Connor - Los Gatos CA, US
Scott Hecker - Del Mar CA, US
Inez Lees - Mountain View CA, US
Grace Quaker - San Francisco CA, US
Faleh Salaymeh - Sunnyvale CA, US
Hongmin Zhang - Fremont CA, US
David Bergbreiter - College Station TX, US
Paul Mansky - San Francisco CA, US
YongQi Mu - Los Altos CA, US
Michael James Cope - Berkeley CA, US
Elizabeth Goka - San Jose CA, US
Angela Lee - San Jose CA, US
Deidre Madsen - Los Altos CA, US
Jun Shao - Fremont CA, US
Kalpesh Biyani - Fremont CA, US
Eric Connor - Los Gatos CA, US
Scott Hecker - Del Mar CA, US
Inez Lees - Mountain View CA, US
Grace Quaker - San Francisco CA, US
Faleh Salaymeh - Sunnyvale CA, US
Hongmin Zhang - Fremont CA, US
David Bergbreiter - College Station TX, US
Paul Mansky - San Francisco CA, US
YongQi Mu - Los Altos CA, US
Michael James Cope - Berkeley CA, US
Elizabeth Goka - San Jose CA, US
Angela Lee - San Jose CA, US
Deidre Madsen - Los Altos CA, US
Jun Shao - Fremont CA, US
Assignee:
RELYPSA, INC. - Santa Clara CA
International Classification:
C08F 226/02, A61P 3/06, A61K 31/785
US Classification:
424 7835, 526304
Abstract:
The present invention provides a crosslinked amine and amide polymers effective for binding and removing bile salts from the gastrointestinal tract. These bile acid binding polymers or pharmaceutical compositions thereof can be administered to subjects to treat various conditions, including hypercholesteremia, diabetes, pruritis, irritable bowel syndrome-diarrhea (IBS-D), bile acid malabsorption, and the like.
Pharmaceutical Compositions Comprising Cross-Linked Small Molecule Amine Polymers
US Patent:
7608674, Oct 27, 2009
Filed:
Nov 3, 2004
Appl. No.:
10/980991
Inventors:
Eric Connor - Los Gatos CA, US
Dominique Charmot - Campbell CA, US
Han-Ting Chang - Livermore CA, US
Florence Roger - Preverenges, CH
Gerrit Klaerner - Los Gatos CA, US
Son Hoai Nguyen - San Jose CA, US
Jonathan Mills - San Jose CA, US
Jerry M. Buysse - Los Altos CA, US
Angela Lee - San Jose CA, US
Deidre Madsen - Sunnyvale CA, US
Jun Shao - Fremont CA, US
Michael J. Cope - Berkeley CA, US
John Fordtran - Dallas TX, US
Dominique Charmot - Campbell CA, US
Han-Ting Chang - Livermore CA, US
Florence Roger - Preverenges, CH
Gerrit Klaerner - Los Gatos CA, US
Son Hoai Nguyen - San Jose CA, US
Jonathan Mills - San Jose CA, US
Jerry M. Buysse - Los Altos CA, US
Angela Lee - San Jose CA, US
Deidre Madsen - Sunnyvale CA, US
Jun Shao - Fremont CA, US
Michael J. Cope - Berkeley CA, US
John Fordtran - Dallas TX, US
Assignee:
Ilypsa, Inc. - Thousand Oaks CA
International Classification:
C11D 1/00, C08F 26/06
US Classification:
526310, 526258, 525334, 424 7806, 424 7811, 424 7812, 424 7816
Abstract:
Anion-binding polymers are described. The anion-binding polymers in some cases are low swelling anion-binding polymers. In some cases, the anion-binding polymers have a pore volume distribution such that a fraction of the polymer is not available for non-interacting solutes above a certain percentage of the MW of the target ion for the polymer. In some cases, the anion-binding polymers are characterized by low ion-binding interference, where the interference is measured in, for example, a gastrointestinal simulant, relative to non-interfering buffer. Pharmaceutical composition, methods of use, and kits are also described.